Project Grant HT94252510797
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$218K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
This Project Grant award for $845,928.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support research conducted by The Trustees of Columbia University in the City of New York, Health Sciences Division, to enhance early detection of pancreatic cancer using GPT-embedded electronic health record (EHR) models. The goal is to develop a novel approach that improves predictive performance and interpretability for earlier identification...
The Defense Health Agency awarded a $658,000 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "OVERCOMING IMMUNOTHERAPY RESISTANCE IN CCNE1-AMPLIFIED STOMACH CANCER", is intended to support research to improve treatment options for stomach cancer patients. The 3-year project will run from May 1, 2024 to April 30, 2027....
The Defense Health Agency awarded a $716,069 Project Grant to President And Fellows Of Harvard College, doing business as Harvard Medical School, to conduct research from September 1, 2023 through August 31, 2025. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative research and investigate medical solutions for the...
The Department of the Army Medical Command awarded a $776,293 Project Grant to Albert Einstein College of Medicine to control the burden of metastatic disease in pancreatic ductal adenocarcinoma. The grant was awarded on September 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 14, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $311,000 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support the University of North Carolina at Chapel Hill (UNC-CH) in enhancing clinical trial discovery, matching, and enrollment for pancreatic ductal adenocarcinoma (PDAC) using fine-tuned large language models. The award, which runs from November 1, 2024 to October 31, 2026, will enable UNC-CH to develop innovative...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $388,194 to The Johns Hopkins University to conduct research on "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for critical health challenges. The 3-year project, running from...
This federal Project Grant award of $144,018.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Beckman Research Institute of the City of Hope in conducting a telehealth intervention to impact quality of life and pancreatic cancer survivorship. The award period runs from August 1, 2024 to July 31, 2027. The Project Grant aims to develop and evaluate a telehealth-based intervention to improve outcomes for pancreatic...
This Project Grant award of $610,656.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research by The Trustees of Columbia University in the City of New York to decipher epigenetic mechanisms that dictate poor responses to KRAS inhibition in lung cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations in critical health...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $812,487 to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to conduct research on "Modulating Liver Inflammation to Improve Outcomes in Pancreatic Cancer". The award period runs from September 30, 2025 to September 29, 2028. The University of Pennsylvania, a leading...